Optimizing Immunotherapy Remains a Challenge in NSCLC – OncLive
OncLive |
Optimizing Immunotherapy Remains a Challenge in NSCLC
OncLive In an interview with OncLive, Gandara, director of the Thoracic Oncology Program, professor at UC Davis Comprehensive Cancer Center, and a 2017 Giant of Cancer Care in Lung Cancer, discussed the latest immunotherapy developments in lung cancer … |
